1
Clinical Trials associated with Autologous total tumor mRNA and pp65 fl LAMP mRNA loaded DOTAP liposome vaccine(University of Florida)A Phase I/II Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
The primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT low level or unmethylated in adults only) and (Stratum 2) in pediatric patients with newly diagnosed HGG (pHGG). Funding Source - FDA OOPD
100 Clinical Results associated with Autologous total tumor mRNA and pp65 fl LAMP mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Translational Medicine associated with Autologous total tumor mRNA and pp65 fl LAMP mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Patents (Medical) associated with Autologous total tumor mRNA and pp65 fl LAMP mRNA loaded DOTAP liposome vaccine(University of Florida)
100 Deals associated with Autologous total tumor mRNA and pp65 fl LAMP mRNA loaded DOTAP liposome vaccine(University of Florida)